Effects of low and high doses of inhaled flunisolide and triamcinolone acetonide on basal and dynamic measures of HPA-axis activity in healthy volunteers

Wilson, AM, McFarlane, LC and Lipworth, BJ (1998) Effects of low and high doses of inhaled flunisolide and triamcinolone acetonide on basal and dynamic measures of HPA-axis activity in healthy volunteers. Journal of Clinical Endocrinology and Metabolism, 83 (3). pp. 922-925. ISSN 1945-7197

Full text not available from this repository. (Request a copy)

Abstract

The objective of this study was to evaluate the effects of inhaled flunisolide (FN) and triamcinolone acetonide (TAA) on basal and dynamic adrenocortical activity. A randomized cross-over design was used, comparing placebo (PL), low (L) and high (H) doses of FN (Aerobid; 250μ g/actuation; without spacer; L, 1000 μg; H, 2000 μg/day), and TAA (Azmacort; 100 μg/actuation; with integrated actuator/spacer; L, 800 μg; H, 1600 μg/day). Each dose was given at 0800 and 2200 h for 3 days, and treatments were separated by a 10-day washout. Twelve normal volunteers (mean ± SE age, 24.2 ± 2.4 yr) were studied. After 3 days of treatment, blood samples were taken before ACTH stimulation at 0800 h (10 h after the sixth dose) and after ACTH (0.5 μg) stimulation for determination of serum cortisol. Overnight (starting at 2200 h on the third day of treatment) and early morning urine collections were taken for measurements of urinary cortisol corrected for creatinine excretion. For serum cortisol (pre- and post-ACTH stimulation), there was no significant difference compared with placebo for either drug. Post-ACTH cortisol (nanomoles per L) values were: PL, 666.3; H FN, 617.0; H TAA, 591.4; L FN, 699.2; and L TAA, 686.0. For overnight corrected urinary cortisol/creatinine excretion (nanomoles per mmol) compared with PL (6.4), there was a significant suppression (P < 0.05) at the high dose of both drugs (H FN, 2.6; H TAA, 2.3) but not at the low dose (L FN, 4.2; L TAA, 4.5). Likewise, values for early morning corrected urinary cortisol/creatinine (nanomoles per mmol) showed significant suppression (P < 0.05) only with high doses of both drugs (PL, 39.0; H FN, 26.5; H TAA, 26.6; L FN, 37.2; L TAA, 36.5). The following conclusions were reached. 1) Overnight and early morning corrected urinary cortisol/creatinine excretion was more sensitive at detecting adrenocortical suppression than basal 0800 h serum cortisol or response to 0.5 μg ACTH stimulation. 2) There were no significant differences between inhaled FN (without spacer) and TAA (with integrated actuator/spacer), which only produced detectable adrenocortical suppression at the highest recommended doses and was not associated with impaired adrenal reserve. 3) Even at the high dose, the suppression observed with both drugs is unlikely to be of clinical relevance.

Item Type: Article
Additional Information: Source:RK Note:
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User: EPrints Services
Date Deposited: 25 Nov 2010 11:12
Last Modified: 15 Dec 2022 02:01
URI: https://ueaeprints.uea.ac.uk/id/eprint/14679
DOI: 10.1210/jc.83.3.922

Actions (login required)

View Item View Item